Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 5, 2013, Pages 1930-1938

  Denburg, Michelle R ^a   Tsampalieros, Anne K ^a,c   De Boer, Ian H ^d   Shults, Justine ^a,b   Kalkwarf, Heidi J ^e   Zemel, Babette S ^a   Foerster, Debbie ^a   Stokes, David ^a   Leonard, Mary B ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

24,25 DIHYDROXYVITAMIN D; 25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE RADIOGRAPHY; CALCIUM BLOOD LEVEL; CHILD; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL VOLUMETRIC BONE MINERAL DENSITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FRACTURE; HUMAN; MALE; MINERAL METABOLISM; ONSET AGE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TIBIA; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ADULT; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; BONE RESORPTION; CALCITRIOL; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COHORT STUDIES; ERGOCALCIFEROLS; FRACTURES, BONE; HUMANS; HYPOCALCEMIA; PARATHYROID HORMONE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK; UNITED STATES; YOUNG ADULT;

EID: 84877693151     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4188     Document Type: Article

References (40)

1. Tsampalieros A, Kalkwarf HJ, Wetzsteon RJ, et al. Changes in bone structure and the muscle-bone unit in children with chronic kidney disease. Kidney Int. 2013;83(3):495-502.
2. Jamal SA, Gilbert J, Gordon C, Bauer DC. Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res. 2006;21:543-548.
3. Wesseling-Perry K, Pereira RC, Tseng CH, et al. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 2012;7:146-152.
4. Malluche HH, Mawad HW, Monier-Faugere MC. Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res. 2011; 26:1368-1376.
5. Bhan I, Powe CE, Berg AH, et al. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int. 2012;82:84-89.
6. Bosworth CR, Levin G, Robinson-Cohen C, et al. The serum 24, 25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease. Kidney Int. 2012;82:693-700.
7. Foster BJ, Kalkwarf HJ, Shults J, et al. Association of chronic kidney disease with muscle deficits in children. J Am Soc Nephrol. 2011; 22:377-386.
8. Kalkwarf HJ, Denburg MR, Strife CF, et al. Vitamin D deficiency is common in children and adolescents with chronic kidney disease. Kidney Int. 2012;81:690-697.
9. Terpstra AM, Kalkwarf HJ, Shults J, et al. Bone density and cortical structure after pediatric renal transplantation. J Am Soc Nephrol. 2012;23:715-726.
10. Wetzsteon RJ, Kalkwarf HJ, Shults J, et al. Volumetric bone mineral density and bone structure in childhood chronic kidney disease. J Bone Miner Res. 2011;26:2235-2244.
11. Leonard MB, Elmi A, Mostoufi-Moab S, et al. Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults. J Clin Endocrinol Metab. 2010;95:1681-1689.
12. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109:45-60.
13. Hollis BW. Quantitation of 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol. 1997;282:174-186.
14. Clive DR, Sudhaker D, Giacherio D, et al. Analytical and clinical validation of a radioimmunoassay for the measurement of 1, 25 dihydroxy vitamin D. Clin Biochem. 2002;35:517-521.
15. Gao P, Scheibel S, D'Amour P, et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res. 2001; 16:605-614.
16. Serum-calcium. Lancet. 1979;1:858-859.
17. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20: 629-637.
18. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
19. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666-3672.
20. Powe CE, Ricciardi C, Berg AH, et al. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res. 2011;26:1609-1616.
21. Kovanlikaya A, Loro ML, Hangartner TN, Reynolds RA, Roe TF, Gilsanz V. Osteopenia in children: CTassessment. Radiology. 1996; 198:781-784.
22. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr. 1990;44:45-60.
23. Wetzsteon RJ, Shults J, Zemel BS, et al. Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res. 2009;24:503-513.
24. Clark EM, Ness AR, Tobias JH. Bone fragility contributes to the risk of fracture in children, even after moderate and severe trauma. J Bone Miner Res. 2008;23:173-179.
25. Cooper C, Dennison EM, Leufkens HG, Bishop N, van Staa TP. Epidemiology of childhood fractures in Britain: a study using the general practice research database. J Bone Miner Res. 2004;19: 1976-1981.
26. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478-1483.
27. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol. 2004;15:1943-1951.
28. Block GA, Spiegel DM, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68:1815-1824.
29. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62:245-252.
30. Moe SM, Chertow GM. The case against calcium-based phosphate binders. Clin J Am Soc Nephrol. 2006;1:697-703.
31. Bailey DA, Martin AD, McKay HA, Whiting S, Mirwald R. Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res. 2000;15:2245-2250.
32. Parfitt AM. A structural approach to renal bone disease. J Bone Miner Res. 1998;13:1213-1220.
33. Schober HC, Han ZH, Foldes AJ, et al. Mineralized bone loss at different sites in dialysis patients: implications for prevention. J Am Soc Nephrol. 1998;9:1225-1233.
34. Haussler MR, Whitfield GK, Kaneko I, et al. Molecular Mechanisms of Vitamin D Action. Calcif Tissue Int. 2013;92:77-98.
35. Lieben L, Masuyama R, Torrekens S, et al. Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest. 2012;122:1803-1815.
36. Sanders K, Duque G, Ebeling P, et al. The efficacy of high-dose oral vitamin D3 administered once a year: increased fracture risk is associated with 1,25 vitamin D level at 3-months post dose. J Bone Miner Res. 2012;27(suppl 1). Available at http://www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx? aid-6beb2500-4b8e-472b-8b38-d881cadb80e3 (Abstract). Accessed January 17, 2013.
37. Dubner SE, Shults J, Baldassano RN, et al. Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology. 2009;136:123-130.
38. O'Brien CA, Jia D, Plotkin LI, et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology. 2004;145:1835-1841.
39. Tsampalieros A, Gupta P, Denburg MR, et al. Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J Bone Miner Res. 2013;28(3):480-488.
40. Wong CS, Pierce CB, Cole SR, et al. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol. 2009;4:812-819.